pmid,title,journal,year,drug,disease
40354444,Cardiovascular safety of Janus kinase inhibitors: A pharmacovigilance study from 2012-2023.,PloS one,2025,Baricitinib,Hypertension
40330022,Clinical characteristics and prognosis of COVID-19- associated invasive pulmonary aspergillosis in critically patients: a single-center study.,Frontiers in cellular and infection microbiology,2025,Baricitinib,Hypertension
40004820,Comparative Real-World Analysis of Baseline Demographic Characteristics and Comorbidities in Atopic Dermatitis Patients Initiating Biologics Versus JAK Inhibitors.,Journal of clinical medicine,2025,Baricitinib,Hypertension
39911872,Baricitinib treatment for hospitalized patients with severe COVID-19 on invasive mechanical ventilation: a propensity score-matched and retrospective analysis.,Frontiers in medicine,2025,Baricitinib,Hypertension
39702602,"Effects of 17beta estradiol on blood pressure elevation in ovariectomized rats with collagen-induced arthritis via modulation of oxidative stress, inflammation, fibrosis, and apoptosis in the aorta involving TLR4/NOX4/NF-kbeta and TGFbeta1/fibronectin/alpha-SMA pathways.",Naunyn-Schmiedeberg's archives of pharmacology,2025,Baricitinib,Hypertension
39291185,Design and Rationale of the Phase 2 Baricitinib Study in Apolipoprotein L1-Mediated Kidney Disease (JUSTICE).,Kidney international reports,2024,Baricitinib,Hypertension
39051163,Successful management of pulmonary hypertension with baricitinib in a dermatomyositis patient.,Clinical and experimental rheumatology,2025,Baricitinib,Hypertension
39003114,Adverse reactions to Janus kinase inhibitors: Study of their incidence and predictive factors in patients with rheumatoid arthritis.,Medicina clinica,2024,Baricitinib,Hypertension
38838223,Interferon-gamma induces combined pyroptotic angiopathy and APOL1 expression in human kidney disease.,Cell reports,2024,Baricitinib,Hypertension
38530666,JAK inhibitors in the treatment of adult patients with juvenile idiopathic arthritis: a retrospective monocentric experience.,Clinical and experimental rheumatology,2024,Baricitinib,Hypertension
38190753,Case Report: Cryptococcal Meningitis in a Previously Immunocompetent Patient with Coronavirus Disease 2019.,The American journal of tropical medicine and hygiene,2024,Baricitinib,Hypertension
38113577,Clinical features of pneumothorax associated with COVID-19: A retrospective analysis of two centres.,Respiratory investigation,2024,Baricitinib,Hypertension
38006372,Erythrodermic Presentation of Atopic Dermatitis in a Patient with Secondary Adrenal Insufficiency Caused by Oral Glucocorticosteroid Abuse.,Acta dermatovenerologica Croatica : ADC,2023,Baricitinib,Hypertension
37933613,Pyrazole: an emerging privileged scaffold in drug discovery.,Future medicinal chemistry,2023,Baricitinib,Hypertension
37868999,Safety of JAK and IL-6 inhibitors in patients with rheumatoid arthritis: a multicenter cohort study.,Frontiers in immunology,2023,Baricitinib,Hypertension
37448334,Out-of-Hospital Cardiac Arrest in Individuals With Human Immunodeficiency Virus: A Nationwide Population-Based Cohort Study.,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,2023,Baricitinib,Hypertension
37332847,Case report: Spontaneous hemothorax following anticoagulation for microthrombi in severe COVID pneumonia.,Respiratory medicine case reports,2023,Baricitinib,Hypertension
37269741,JAK2/STAT5 inhibition protects mice from experimental autoimmune encephalomyelitis by modulating T cell polarization.,International immunopharmacology,2023,Baricitinib,Hypertension
37042600,NEUROPROTECTIVE AND ANTIOXIDANT POTENTIAL OF MONTELUKAST-ACETYLCYSTEINE COMBINATION THERAPY FOR BRAIN PROTECTION IN PATIENTS WITH COVID-19 INDUCED PNEUMONIA.,Georgian medical news,2023,Baricitinib,Hypertension
37013725,Adverse events in patients treated with Jak-inhibitors for alopecia areata: A systematic review.,Journal of the European Academy of Dermatology and Venereology : JEADV,2023,Baricitinib,Hypertension
36851998,Risk of Underlying Diseases and Effectiveness of Drugs on COVID-19 Inpatients Assessed Using Medical Claims in Japan: Retrospective Observational Study.,International journal of general medicine,2023,Baricitinib,Hypertension
36802049,Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications.,Advances in therapy,2023,Baricitinib,Hypertension
36350405,[Nephrological management and drug dosing in patients with rheumatic diseases and renal insufficiency].,Zeitschrift fur Rheumatologie,2022,Baricitinib,Hypertension
36106228,Bilateral Recurrent Laryngeal Nerve Paralysis Manifesting as Long COVID.,Cureus,2022,Baricitinib,Hypertension
35920701,Concurrent bullous pemphigoid and plaque psoriasis successfully treated with Janus kinase inhibitor Baricitinib.,Dermatologic therapy,2022,Baricitinib,Hypertension
35699028,Characterizing real world safety profile of oral Janus kinase inhibitors among adult atopic dermatitis patients: evidence transporting from the rheumatoid arthritis population.,Current medical research and opinion,2022,Baricitinib,Hypertension
34554329,Risk of venous thromboembolism associated with Janus kinase inhibitors for rheumatoid arthritis: case presentation and literature review.,Clinical rheumatology,2021,Baricitinib,Hypertension
34250455,Intracerebral bleeding after Janus-kinase inhibitor baricitinib for COVID-19.,Brain hemorrhages,2021,Baricitinib,Hypertension
34131629,Update on biologic therapies for juvenile idiopathic arthritis-associated uveitis.,Annals of eye science,2021,Baricitinib,Hypertension
33969237,The use of Janus Kinase inhibitors in hospitalized patients with COVID-19: Systematic review and meta-analysis.,Clinical epidemiology and global health,2021,Baricitinib,Hypertension
33455920,Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?,RMD open,2021,Baricitinib,Hypertension
33391477,Immunopathogenesis and treatment of cytokine storm in COVID-19.,Theranostics,2021,Baricitinib,Hypertension
33253920,"Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic.",Drug discovery today,2021,Baricitinib,Hypertension
33029696,Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.,Molecular and cellular biochemistry,2021,Baricitinib,Hypertension
32696108,Pharmaco-Immunomodulatory Therapy in COVID-19.,Drugs,2020,Baricitinib,Hypertension
32641154,Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial.,Trials,2020,Baricitinib,Hypertension
29481660,JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial.,"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association",2018,Baricitinib,Hypertension
27268955,Targeting inflammation in diabetic kidney disease: early clinical trials.,Expert opinion on investigational drugs,2016,Baricitinib,Hypertension
